Clinical Trial Update: A Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors and Tamoxifen

View source ↗

Summary

The document reports a completed clinical trial update that prospectively assesses how baseline body mass index relates to loss of grip strength in breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthralgia
• Breast Cancer

Drugs mentioned

• Aromatase inhibitors (aromatase inhibitor)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Breast Cancer, Arthralgia | Status: COMPLETED